95 Peginterferon alfa-2A (40KD) (PEGASYS®) monotherapy is more effective than lamivudine monotherapy in the treatment of HBEAG-negative chronic hepatitis B: 72-week results from a phase III, partially double-blind study of PEGASYS® alone vs PEGASYS® plus lamivudine vs lamivudine
- 31 December 2004
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: